I am a board-certified assistant attending medical physicist in the Dosimetry Core of the Clinical Physics Service. I have contributed to various roles from commissioning treatment machines and treatment planning systems (TPS) to clinical research and development. I am currently leading the effort in commissioning and establishing the quality assurance (QA) program of MR LINAC and the in-house solution for independent calculation. I am also involved in the development of a new machine QA program that will provide a scalable standardized workflow and a more quantitative approach for network-wide monitoring and analysis.
As the leader of the TPS, I use the latest technology to improve the accuracy and precision of radiation treatment delivery. I am also involved in training medical physics residents in the area of QA and commissioning.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Seng Boh Lim discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.